We aimed to examine specialist palliative care (SPC) involvement and end-of-life care for patients with MM

This retrospective cohort study used 2013-2018 commercial and Medicare claims data to assess medication use in adults with MM

To evaluate impact of time to transplant on subsequent outcomes, we analyzed data on consecutive MM patients who received novel agents-based induction...

Despite the introduction of new and better treatments, rapidly implemented in our countries, our registries uncover subgroups of patients that still...

Our results describe the mechanisms of miR-induced T-cell exhaustion, which provide a foundation for developing synthetic anti-miRs to therapeutically...

We find that patients with CTCL are at increased risk of second malignancies, especially Hodgkin and non-Hodgkin lymphoma, lung cancer, bladder cancer...

Prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects contributing to functional impairment and disability in HL...

We hypothesized that murine double minute X (MDMX), a negative p53-regulator, may be involved in dysfunctional p53-signaling in anaplastic large cell...

This extended series supports that allo-HSCT is able to effectively rescue over one third of the population of patients with advanced-stage MF/SS

Pediatric Hodgkin lymphoma (pHL) is highly curable. However, a minority experience relapse and are subjected to toxic salvage regimens

We performed a pairwise comparative analysis of early response to first- and second-line treatments in 127 patients with classic HL who experienced...

Treatment regimens for pediatric Hodgkin's lymphoma (HL) depend on accurate staging and treatment response assessment, based on accurate disease...